Medico Remedies logo

Medico Remedies

MEDICO NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹292 Cr
Volatility
Low Risk
P/E Ratio
22.19
EBITDA
₹23.00 Cr
Return on Equity
17.38%
Debt to Equity
0.25
Book Value
₹9.1
52W High
₹56.88
52W Low
₹30.22

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 38.3% CAGR over last 5 years

Weaknesses

4
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 11.0% over past five years.
  • Earnings include an other income of Rs.6.44 Cr.
  • Promoter holding has decreased over last 3 years: -12.0%

Growth Rate

Revenue Growth
38.22% higher than 3Y
Net Income Growth
29.7% higher than 3Y
Cash Flow Change
20.04% lower than 3Y
ROE
7.55% lower than 3Y
ROCE
12.39% lower than 3Y
EBITDA Margin (Avg.)
-6.16% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
31.47
42.36
29.77
41.32
30.8
39.35
39.49
41.3
38.25
52.64
58.68
56.81
69.4
Expenses
29.01
39.29
27.04
36.67
27.98
36.94
36.38
34.64
35.43
49.91
54.35
49.66
66.1
Operating Profit
2.46
3.07
2.73
4.65
2.82
2.41
3.11
6.66
2.82
2.73
4.33
7.15
3.3
OPM %
7.82%
7.25%
9.17%
11.25%
9.16%
6.12%
7.88%
16.13%
7.37%
5.19%
7.38%
12.59%
4.76%
Other Income
0.31
0.96
0.27
0.58
0.29
0.68
1.43
0.29
0.66
1.72
0.68
2.87
1.17
Interest
0.17
0.18
0.22
0.25
0.18
0.21
0.28
0.49
0.28
0.24
0.39
0.9
0.41
Depreciation
0.71
0.71
0.72
0.74
0.75
0.75
0.76
0.77
0.77
0.73
0.79
0.8
0.72
PBT
1.89
3.14
2.06
4.24
2.18
2.13
3.5
5.69
2.43
3.48
3.83
8.32
3.34
Tax %
29.63%
22.61%
30.1%
26.89%
27.06%
27.23%
25.14%
23.9%
25.51%
25.86%
25.07%
29.69%
24.55%
Net Profit
1.32
2.43
1.45
3.1
1.58
1.55
2.62
4.34
1.82
2.57
2.87
5.86
2.52
EPS in Rs
0.16
0.29
0.17
0.37
0.19
0.19
0.32
0.52
0.22
0.31
0.35
0.71
0.3
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
51
67
54
61
98
89
122
121
140
145
151
206
238
Expenses
48
63
50
58
95
86
117
114
131
132
136
189
220
Operating Profit
3
4
4
3
3
3
5
7
10
13
15
17
18
OPM %
6%
5%
7%
6%
2.8%
3.2%
4.3%
6%
7%
9%
10%
8%
7%
Other Income
0
0
0
1
2
2
1
2
4
2
3
6
6
Interest
1
1
1
2
1
1
1
1
1
1
1
2
2
Depreciation
1
1
1
1
2
2
2
2
3
3
3
3
3
PBT
1
2
2
2
2
2
4
6
10
11
14
18
19
Tax %
28%
40%
4%
35%
28%
26%
30%
26%
28%
27%
25%
27%
—
Net Profit
1
1
2
1
2
2
3
5
7
8
10
13
14
EPS in Rs
0.25
0.35
0.25
0.15
0.19
0.2
0.31
0.58
0.87
1
1.22
1.58
1.67
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
2
2
3
4
4
4
4
17
17
17
17
17
Reserves
12
13
13
23
24
26
28
20
27
36
46
59
Borrowings
8
14
19
13
14
14
15
13
10
8
14
19
Other Liabilities
14
17
13
20
35
32
28
28
34
36
43
59
Total Liabilities
36
46
48
59
76
75
76
77
87
96
120
153
Fixed Assets
8
7
7
7
12
13
15
18
22
21
21
20
CWIP
0
0
3
4
1
2
0
0
0
0
0
3
Investments
1
1
0
0
0
0
1
0
1
2
2
2
Other Assets
27
38
39
48
63
60
59
59
64
73
96
129
Total Assets
36
46
48
59
76
75
76
77
87
96
120
153
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
—
-3
5
5
1
-11
6
8
2
5
6
Investing
—
—
-3
-5
-4
-3
-17
-2
-7
-3
-3
-5
Financing
—
—
6
-1
-1
3
18
-6
-2
0
-1
-1
Net Cash Flow
—
—
0
0
0
0
-10
-2
0
-1
1
1
Free Cash Flow
—
—
-4
3
1
-2
-28
3
2
0
2
1
CFO/OP
—
—
-68
162
198
53
-198
104
111
43
58
64
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
53
107
122
102
109
98
82
92
94
125
138
145
Inventory Days
76
63
96
125
74
99
58
76
69
54
90
72
Days Payable
122
106
112
147
149
143
100
113
108
105
117
119
Cash Conversion Cycle
6
64
105
80
33
54
39
54
54
75
111
98
Working Capital Days
21
53
110
88
49
61
50
52
54
74
90
84
ROCE %
10%
11%
10%
9%
8%
8%
10%
15%
21%
21%
21%
23%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Medico Remedies insights

63 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Shareholding Pattern

FIIs0.08%Promot.61.38%Others14.86%Public23.68%As ofJun 2026

Documents

Frequently Asked Questions about Medico Remedies

What does Medico Remedies Ltd do?
Incorporated in 1994, Medico Remedies Ltd manufactures and sells pharmaceutical formulations[1]
Where is Medico Remedies Ltd (MEDICO) listed?
Medico Remedies Ltd trades as MEDICO on the NSE and under code 540937 on the BSE.
Which sector does Medico Remedies Ltd belong to?
Medico Remedies Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Medico Remedies Ltd?
Medico Remedies Ltd has a market capitalisation of ₹292.19 Cr, which places it in the Small Cap band.
What is the PE ratio of Medico Remedies Ltd?
Medico Remedies Ltd trades at a PE ratio of 22.19, against a book value of ₹9.1 per share.
What is the 52-week high and low of Medico Remedies Ltd?
Over the last 52 weeks Medico Remedies Ltd has traded between ₹30.22 and ₹56.88.
What is the Return on Equity (ROE) of Medico Remedies Ltd?
Medico Remedies Ltd reported a return on equity of 17.38%. Its debt-to-equity ratio is 0.25.

Company Information

Incorporated in 1994, Medico Remedies Ltd manufactures and sells pharmaceutical formulations[1]

Website medicoremedies.com
CEO Mr. Haresh Kapurlal Mehta
Employees 213
Listed 2022-05-26
Face Value ₹ 2
Issued Size 8,29,84,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/MEDICO.md for Medico Remedies Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List